Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity
Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity
复制标题
合并糖尿病合并症的结核病治疗导致血液转录组分辨率受损
DOI:
10.1101/2022.02.07.22269422
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Eckold C
中科院分区:
文献类型:
--
作者:
Eckold C
BackgroundPeople with diabetes are more likely to develop tuberculosis (TB) and to have poor TB‐treatment outcomes than those without. We previously showed that blood transcriptomes in people with TB‐diabetes (TB‐DM) co‐morbidity have excessive inflammatory and reduced interferon responses at diagnosis. It is unknown whether this persists through treatment and contributes to the adverse outcomes.MethodsPulmonary TB patients recruited in South Africa, Indonesia and Romania were classified as having TB‐DM, TB with prediabetes, TB‐related hyperglycaemia or TB‐only, based on glycated haemoglobin concentration at TB diagnosis and after 6 months of TB treatment. Gene expression in blood at diagnosis and intervals throughout treatment was measured by unbiased RNA‐Seq and targeted Multiplex Ligation‐dependent Probe Amplification. Transcriptomic data were analysed by longitudinal mixed‐model regression to identify whether genes were differentially expressed between clinical groups through time. Predictive models of TB‐treatment response across groups were developed and cross‐tested.ResultsGene expression differed between TB and TB‐DM patients at diagnosis and was modulated by TB treatment in all clinical groups but to different extents, such that differences remained in TB‐DM relative to TB‐only throughout. Expression of some genes increased through TB treatment, whereas others decreased: some were persistently more highly expressed in TB‐DM and others in TB‐only patients. Genes involved in innate immune responses, anti‐microbial immunity and inflammation were significantly upregulated in people with TB‐DM throughout treatment. The overall pattern of change was similar across clinical groups irrespective of diabetes status, permitting models predictive of TB treatment to be developed.ConclusionsExacerbated transcriptome changes in TB‐DM take longer to resolve during TB treatment, meaning they remain different from those in uncomplicated TB after treatment completion. This may indicate a prolonged inflammatory response in TB‐DM, requiring prolonged treatment or host‐directed therapy for complete cure. Development of transcriptome‐based biomarker signatures of TB‐treatment response should include people with diabetes for use across populations.
登录
查看更多内容
DOI:
10.1093/bioinformatics/btu638
发表时间:
2015-01-15
期刊:
Bioinformatics (Oxford, England)
影响因子:
--
作者:
Anders S;Pyl PT;Huber W
通讯作者:
Huber W
影响因子:
9.1
作者:
Geluk, Annemieke;van Meijgaarden, Krista E.;Ottenhoff, Tom H. M.
通讯作者:
Ottenhoff, Tom H. M.
DOI:
--
发表时间:
2013
期刊:
--
影响因子:
--
作者:
Florencia Aguiree;Alex Brown;N. H. Cho;G. Dahlquist;S. Dodd;T. Dunning;Michael Hirst;Christopher K Hwang;D. Magliano;C. Patterson;Courtney Scott;Jonathon Shaw;G. Soltész;J. Usher-Smith;D. Whiting
通讯作者:
Florencia Aguiree;Alex Brown;N. H. Cho;G. Dahlquist;S. Dodd;T. Dunning;Michael Hirst;Christopher K Hwang;D. Magliano;C. Patterson;Courtney Scott;Jonathon Shaw;G. Soltész;J. Usher-Smith;D. Whiting
影响因子:
3.7
作者:
Kumar NP;Banurekha VV;Nair D;Sridhar R;Kornfeld H;Nutman TB;Babu S
通讯作者:
Babu S
影响因子:
6.4
作者:
Boillat-Blanco, Noemie;Ramaiya, Kaushik L.;Probst-Hensch, Nicole
通讯作者:
Probst-Hensch, Nicole